Frontiers in Aging Neuroscience,
Journal Year:
2019,
Volume and Issue:
11
Published: Dec. 11, 2019
Post-stroke
systemic
injections
of
insulin-like
growth
factor
1
(IGF-1)
exert
neuroprotective
effects
in
rats.
In
the
current
study,
we
aimed
to
test
efficacy
IGF-1
neuroprotection
aged
rats
(24-25
months
old)
and
compare
results
with
adult
(6-7
old).
Furthermore,
addressed
putative
differences
microglial
responses
Rats
were
subjected
ischemic
stroke
while
they
conscious
by
infusing
endothelin-1
(Et-1)
through
a
guide
cannula
that
was
implemented
vicinity
middle
cerebral
artery
(MCA).
given
subcutaneous
(1
mg/kg)
at
30
min
120
after
insult.
treatment
reduced
infarct
size
34%
38%
rats,
respectively.
The
treated
also
showed
significant
improvement
sensorimotor
function
following
stroke,
this
not
significantly
affected
displayed
exaggerated
activation
microglia
hemisphere.
Significant
reduction
only
detected
specific
regions
ipsilateral
hemisphere
We
show
an
stroke.
It
remains
be
established,
however,
whether
age-related
changes
affect
behavioral
outcome.
iScience,
Journal Year:
2023,
Volume and Issue:
26(5), P. 106669 - 106669
Published: April 14, 2023
The
ubiquitous
volume-regulated
anion
channels
(VRACs)
facilitate
cell
volume
control
and
contribute
to
many
other
physiological
processes.
Treatment
with
non-specific
VRAC
blockers
or
brain-specific
deletion
of
the
essential
subunit
LRRC8A
is
highly
protective
in
rodent
models
stroke.
Here,
we
tested
widely
accepted
idea
that
harmful
effects
VRACs
are
mediated
by
release
excitatory
neurotransmitter
glutamate.
We
produced
conditional
knockout
either
exclusively
astrocytes
majority
brain
cells.
Genetically
modified
mice
were
subjected
an
experimental
stroke
(middle
cerebral
artery
occlusion).
astrocytic
yielded
no
protection.
Conversely,
brain-wide
strongly
reduced
infarction
both
heterozygous
(Het)
full
KO
mice.
Yet,
despite
identical
protection,
Het
had
swelling-activated
glutamate
release,
whereas
animals
showed
its
virtual
absence.
These
findings
suggest
contributes
ischemic
injury
via
a
mechanism
than
VRAC-mediated
release.
Journal of Cerebral Blood Flow & Metabolism,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 20, 2025
Stroke-associated
mood
disorders
are
less
recognised
than
sensorimotor
impairment,
despite
their
high
prevalence.
Similarly,
few
experimental
stroke
studies
assess
non-sensorimotor
functions.
This
study
examined
the
prevalence
and
implementation
of
tests
in
three
stroke-focused
journals
over
last
twenty
years.
Of
965
ischaemic
papers
which
used
behavioural
testing
rodents,
932
included
testing,
while
137
(most
commonly
Morris
water
maze,
open
field,
Y-maze,
novel
object
recognition
tests,
but
with
a
more
diverse
range
introduced
recent
years).
Cognition,
anxiety
depression
were
assessed
70%,
27%
3%
these
papers.
Non-sensorimotor
deficits
typically
observed
after
recovery
function.
Potential
confounding
factors
challenges
for
data
interpretation
identified
most
prevalent
tests.
More
generally,
rigor
(a
priori
power
calculation,
randomisation,
blinding,
pre-defined
inclusion/exclusion)
improved
years,
remained
unsatisfactory
only
26%
providing
some
evidence
adequate
statistical
power.
Furthermore,
focused
on
male
animals,
limiting
external
validity.
review
confirms
disparity
between
shows
that
share
including
latter
is
increasing.
It
essential
research
into
neuropsychiatric
sequalae
addresses
methodological
issues
noted
continues
to
expand
improve
patient
outcomes
post-stroke.
Frontiers in Aging Neuroscience,
Journal Year:
2019,
Volume and Issue:
11
Published: Dec. 11, 2019
Post-stroke
systemic
injections
of
insulin-like
growth
factor
1
(IGF-1)
exert
neuroprotective
effects
in
rats.
In
the
current
study,
we
aimed
to
test
efficacy
IGF-1
neuroprotection
aged
rats
(24-25
months
old)
and
compare
results
with
adult
(6-7
old).
Furthermore,
addressed
putative
differences
microglial
responses
Rats
were
subjected
ischemic
stroke
while
they
conscious
by
infusing
endothelin-1
(Et-1)
through
a
guide
cannula
that
was
implemented
vicinity
middle
cerebral
artery
(MCA).
given
subcutaneous
(1
mg/kg)
at
30
min
120
after
insult.
treatment
reduced
infarct
size
34%
38%
rats,
respectively.
The
treated
also
showed
significant
improvement
sensorimotor
function
following
stroke,
this
not
significantly
affected
displayed
exaggerated
activation
microglia
hemisphere.
Significant
reduction
only
detected
specific
regions
ipsilateral
hemisphere
We
show
an
stroke.
It
remains
be
established,
however,
whether
age-related
changes
affect
behavioral
outcome.